butyric acid has been researched along with paclitaxel in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emanuele, S; Giuliano, M; Lauricella, M; Tesoriere, G; Vento, R | 1 |
| Argov, M; Bod, T; Cohen, K; Margalit, R; Rivkin, I | 1 |
| Hearne, JL; Kiessu, E; Martin-Caraballo, M; Puplampu-Dove, YA; Weaver, EM; Zamora, FJ | 1 |
| Avagliano, C; Aviello, G; Cimmino, F; Coretti, L; Cristiano, C; Cuozzo, M; Lembo, F; Liguori, FM; Mollica, MP; Russo, R; Turco, L | 1 |
4 other study(ies) available for butyric acid and paclitaxel
| Article | Year |
|---|---|
Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells.
Topics: Amsacrine; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Butyrates; Butyric Acid; Camptothecin; Carboplatin; Cisplatin; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Paclitaxel; Retinoblastoma; Suramin; Tumor Cells, Cultured | 1998 |
Cancer cell sensitization and improved treatment efficacy by combined sodium butyrate and paclitaxel formulations is cancer-type specific.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Butyric Acid; Cell Cycle; Cell Differentiation; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; HeLa Cells; HT29 Cells; Humans; Paclitaxel; Treatment Outcome | 2014 |
Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Topics: Butyric Acid; Calcium Channels, T-Type; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Histone Deacetylase Inhibitors; Humans; Male; Paclitaxel; Prostatic Neoplasms; Thapsigargin | 2015 |
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction.
Topics: Animals; Butyric Acid; Carcinoma, Non-Small-Cell Lung; Dietary Supplements; Gastrointestinal Microbiome; Intestinal Diseases; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel | 2022 |